67
Views
42
CrossRef citations to date
0
Altmetric
Research Article

GOLD AND ITS RELATIONSHIP TO NEUROLOGICAL/GLANDULAR CONDITIONS

, , &
Pages 31-53 | Published online: 07 Jul 2009

  • Abraham, G. E. (1996). Management of rheumatoid arthrins rationale for the use of colloidal metallic gold. Terrace, CA: Optimor Corporation.
  • Abraham, G. E., & Himmel, P. B. (1997). Management of rheumatoid arthritis: Rationale for the use of colloidal metallic gold, Journal of Nutritional and Environmental Medicine. 7. 295-305.
  • Abraham, G. E. McReynolds, S. A., & Dill, J. S. (1998). Effect of colloidal metallic gold on cognitive functions,' A pilot study. Frontier Perspectives. 7. 39-41.
  • Alexiou, D., Grimanis, A. P., Grimani, M., Papuevangelou, G., Koumantukis, E., & Papadaios, C. (1977). Trace elements (zinc cubalt, selenium, rubidium, bromine, gold) in human placeman and newborn liver at birth. Pediatric Research. 11, 646-648.
  • Anderson, C. W. N., Brooks, R. R., Stewart, R. B., & Simcuck, R. (1998). Harvesting u crop of gold in plants. Nature, 395. 553-554.
  • Atkins, H. L. Lambrecht. R M., Wolf, A. P., Ansari. A. N. & Gurllaume, M. (1975). Distribution of various labeled thinglucoses in rodents, Radiology, 115. 723-725.
  • Bajaj. S., & Voltoru, S. B. (1998). Analgesic activity of gold preparations used in Ayurved & Unani-Tibb. Indian Journal of Medical Research. 108, 104-111.
  • Barelay, G. A. (1964). The Kelsey League. Journal of the Illinens Stak Illustrated Society, 57, 341-365.
  • Belt, E. A., & Kaarela. K. (1998). Gold and ring finger [letter]. Annals of Rheunid Disease, 57. 323.
  • Bernstein. I. L., Bernstein, D. I., Dubb, J. W. Failerman. I. & Wallin. B. (1996). A placebo-controlled mull center study of auranotin in the treatment of patients with corticosteroid-dependent asthma. Auranofin Mull center Drug Trial. Journal of Allergy and Clinical lannunplogr, 98, 317-324.
  • Blackwell. T S., & Gassage, J. R. (1995). Gold pulmonary toxicity in a patient with a normal chest radiograph. Southern Medical Journal. 88, 644-646.
  • Blancas, R., Moreno, J.L. Martin, F., de al Casa, R., Onoro, J. J. & Gomez. V. (1998). Alveolar-interstitial pneumopatlry after gold-salts compounds administration. requiring mechanical ventilation. Intensive Care Medicine. 24. 1110-1112.
  • Blech. W., Bierwulf, B., Weiss, L. & Ziegler, M. (1986). In vitro and in vivo effect of gold thioglucose on the insulin- and glucagon-secretion of the isolated perused rat pancreas, Biomedical Biochim Act. 45, 507-522.
  • Bloch, M. (1971). The royal touch. New York: Dorset Press.
  • Bolosiu, H. D. (1998). Protective effect of gold rings and rheumatoid arthritis [letter]. Annals of Rheumatic Disease. 57, 323.
  • Burnett, J. C. (1879). Gold as a remedy in disease. Notably in some forms of organic heart disease. angina pectoris. melancholy, radium vitae. scrofula, skin discuse, and as an antidote to the ill effects of mercury, London: Gould.
  • Callan J. P. (1979). Editorial, Journal of the American Medical Association. 241. 1156.
  • Cayce, E. (1993). The complete edgar cayce readings on CD-ROM. Virginia Beach. VA: A.R.E. Press.
  • Chipman, J. J., Boyar, R. M., & Finl, C. W. (1981). Anterior-pituitary adrenal function of gold-treated patients with juvenile rheumatoid arthritis. journal of Rheumatology, 9, 63-68.
  • Clark, C. S. (1895). The perfect Keeley cure. Milwaukee: C. S. Clark.
  • Clark, G., & Kasten, F. H. (1983). History of staining. Baltimore: Williams & Wilkins.
  • Dalziel, K., Going, G., Carwright, P. H., Makrs, R., Bever Rowell, N. R. (1986). Treatment of chronic discoid lupus crythematosus with an oral gold compound (muranofln). British Journal of Dermatology, 115, 211-216.
  • Dorland, W. N. (1908). The American illustrated medical dictionary. Philadelphia: W.B. Saunden Company.
  • Eichhorst, H. (1886). Handbook of practical medicine. Volume I. Disease of the circulatory and respiratory apparatus. New York: William Wood and Company.
  • El-Yuzigi. A., Al-Saleh, L. & Al-Mefty, O. (1984). Concentrations of Ag, Au, Br, CJ, Cu. Pb, Sb, and Se in cerebrospinal fluid of patients with cerebral neoplasm's. Clinical Chemistry. 30, 1358-1360.
  • El-Yazigi. A., Kanaan, I. Martin, C. R., & Siqueira, E. B. (1990). Cerebrospinal fluid content of manganese, platinum and strontium in patents with cerebral tumor, leukemia, and other noncerebral neoplasm's. Oncology, 47, 385-388.
  • Erhardt, R., Fischer, U., Fischer, B., & Kern, I. (1978). Cerebra-organic syndrome during gold therapy, Possible correlation between gold therapy in chronic seronegative polyarthritis and the appearance of a cerebra-organic syndrome. A case contribution. Fortschritre Der Medizin, 90, 581-585.
  • Fam, A. G. Gordon, D. A., Sarkozi, L. Blair, G. R. Cooper, P. W., Harth, M., & Lewis, A. J. (1984). Neuralgic complications associated with gold therapy for rheumatoid arthritis. Journal of Rheumutology. 11, 700-706.
  • Fomon, S. (1920). Medicine and the allied sciences. Volume III. New York: D. Appleson and Company.
  • Forestier, J. (1935). Rheumatoid arthritis and its treatment by gold salts. Journal of Laboratory and Clinical Medicine, 20, 827-840.
  • Fricker, S. P. (1996). Medical uses of gold compounds: Past, present and future. Gold Bulletin, 29, 53-60.
  • Fricker, S. P. (1998). 4th International conference on gold and silver in medicine. Gold Bulletin, 31, 103-104.
  • Garber, S. T. (192). Stedman's practical media al dictionary Baltimore: Williams & Wilkins.
  • Gooddy, W., Williams, T. R., & Nicholas, D. (1974). Spark-source mass spectrometry in the investigation of neurological disease. I. Multi-element analysis in blood and cerebrospinal fluid, Brain, 97, 327-336.
  • Goodman, A. G., Ralf. T. W., Nies, A. S., & Taylor P. (1990) Goodman and Gilman's The pharmacological basis of therupeutins New York: Pergamon Press.
  • Goodwin, J. S., & Goodwin, J. M. (1985). The tomato effect, Rejection of highly efficacious therapies. Journal of the American Medical Association. 251. 2387-2390.
  • Gulliford, M. C., Archard, N. P., van't Hoff, W. (1985). Gold encephalopathy, British Medical Journal (Clinical Research Edition), 290(6483). 1744.
  • Gurr, E. (1962). Starning. Baltimore: Williams & Wilkins.
  • Hagenfeldt. K., Landgren, B. M., Plantin, L. O., & Divelalusy, E. (1977). Trace elements in the human endometrium and deciduas. Acts Endocrinologiea, 85. 406-414.
  • Hare, H. A. (1912). A text book of practical therapeutics 14th Ed. Philadelphia: Lea 7 Febiger.
  • Higby, G. J. (1982). Gold in Medicine: A review of its use in the West before 1900. Gold Bulletin, 15, 130-140.
  • Hill, C., Pile, K., Henderson, D., & Kirkham, B. (1995). Neurological side effects in two patients receiving gold injections for rheumatoid arthritis. British Journal of Rheumatology, 34, 989-990.
  • Hopper, D. L. & Satterlee, D. G. (1984). Effect of bipiperidyl mustard and gold thioglucose on the hypothalamus and growth of the hatchling chick and duckling. British Poultry Science. 25, 77-82.
  • Kanabrocki, E., Case, L. F., Graham, I. A., Fields, T., Oesler, Y. I. & Kaplan. E. (1968). Neutron activation studies of trace elements in human fingernails. Journal of Nuclear Medicine, 9. 478-481.
  • Kauf, E., Wiesner, W., Niese, S., & Plenert, W. (1984). Zine cupper, manganese and gold content of the hair of infants, Acta Paediatrica Hang. 25, 299-307.
  • Kean, W. F., Forestier, F., Kassam, Y., Buchatran, W. W., & Rooney, P. J. (1985). The history of gold thempy in rheumatoid disease. Seminars in Arthritis and Rheumutism, 14, 180-186.
  • Keeley, L. E. (1897). Opium: Its use alnose and cure. Chicago, IL: The Banner of Gold, Co. [Reprint New York: Arno Press: 1981.]
  • Klinkhoff, A. V., & Tentel, A. (1995). How low can you go? Use of very low dosage of gold in patients with mucocutaneous reactions. Journal of Rheumatology, 22, 1657-1659.
  • Korholz, D., Nurnberger, W., Gubel, U., & Wahn, V. (1988). Gold-induced systemic lupus erythematosus. Monatsschrift Kinderheilked. 136. 644-646.
  • Leake, C. D. (1975). An historical account of phurmucology to the twentieth century. Springfield. II.: Charles C. Thomas.
  • Liebfarth, J. H., & Persellin, R. H. (1981). Mechanisms of action of gold, Agents and Actions. 11. 458-472.
  • Lncke, L. M., & Smith, D. M. (1985). Forty-seven years experience with gold therapy in LD19 rheuntatoid arthritis patients, Seminra in Arthriris and Rheunatisn, 14, 238-246.
  • Mahdihassan, S. (1985). Cinnabar-gold as the best alehemical drug of longevity, called Makaradhwaja in India. American Journal of Chinese Medicine, 13, 93-108.
  • Mahler, D. J., Scott, A. F., Walsh, J. R., & Haynie, G. (1970) A study of trace metals in fingernails and hair using neutron activation analysis. Journal of Nuclear Medicine. 11. 739-742.
  • McAuley, D. L, Lecky, B. R., & Earl, C. J. (1977) Gold encephalopathy. Journal of Neurology Neurologery, and Psychildry, 40. 102-1022.
  • Merch's 1899 Manual of the Materia Mrdival, New york: Merck & Co. [Reprint 1999]
  • Mertz, W. (1998). Review of the scientific basis for establishing the essentiality of trace elements. Bilogical Trace Element Research, 56. 185-191.
  • Mulherin, D. M., Struthers, G. R., & Situnayake, R. D. (1997). Do gold rings protect against articular crosion in rheumatoid arthritis? Annals of Rheumuk Discuse. 56, 497-499.
  • Niel, J. G., Chrestien, J. A. (1821). Recharches et observations sur les effets des preparations d' or du dr. Chrestien dans le truitement de plustemrs malodies et notumment daas celui des maladies syphiliques. Paris, Gahon: J. A. Chrestien.
  • Nielsen, F. H. (1985). The importance of diet compusition in ultratrace element research. Journal of Nutrition, 115, 1239-1247.
  • Nielsen, F. H. (1990). New essential trace elements for the life sciences. Biological Truce Element Research, 26-27. 599-611.
  • Nierop, G., Gijzel, W. P.,. Bel, E. H., Zwinderman, A. H., & Dijkman, J. H. (1992). Auranofin in the treatment of steruid dependent asthma: A double blind study. Thoras. 47. 349-354.
  • Perry, R. P., & Jacobsen, E. S. (1984). Gold induced encephalopathy: Case report, Journal of Rheumatology, 11, 233-234.
  • Polak, J. M., & Vurndell, I. M. (eds).(1984). Immunolaheling for electron mis roscopy. New York: Elsevier.
  • Potter, S. O. L. (1894). A compend of materia medica. therapeuties. and prescription writing, with especial reference to the physiological actions of drugs. 6th Ed., 1902. Philadelphia: P. Blakiston's Sons & Co.
  • Ramony y Cajal, S. (1995). Histolugy of the accrous system. New York: Oxford University Press.
  • Ryan, M., & Baumann, R. J. (1999). Use and Monitoring of bromides in epilepsy treatment. Pediatric Neurology, 21, 523-528.
  • Schlumpf, U., Meyer, M., Ulrich, J., & Friede, R. L. (1983). Neurologic complications induced by gold treatment. Arthriris and Rhemmatism, 26. 825-831.
  • Scott, D. F. (1992). The first use of lithium [letter], British Journal of psychiutry, 160. 709-710.
  • Skandhan, K. P., & Abraham, K. C. (1984). Presence of several elements in normal and pathological human semen samples and its origin. Andrologia, 16, 587-588.
  • Speight. T. M. & Holford, N. H. G. (1997). Avery's drug treatment, 4th Ed. Philadelphia: Adis International.
  • Taylor, A. (1985). Therapeutic uses of trace elements. Clinical Endocrinology and Metubolism, 14, 703-724.
  • Ternkin, O. (1971). The falling sickness. A history of epilepsy from the Greeks to the beginnings of modern metunology. Baltimore: Johns Hopkins Press.
  • Thomas, L. (1987). Gold therupy and its indications in dermatology. Journal of the American Academy of Dermatology, 16, 845-854.
  • Usuba, Y. Alha, S., Hashimota, K., Tanita, Y., & Sakui. K. (1989). A fatal case of pemphigus vulgaris with interstitial pueumonis occurring during gold therapy. Nippon Hifuka Gakkai Zasshi, 99, 725-730.
  • Vernay, D., Dubost, J. J., Thevenct, J. P., Sauvenme, B., & Rampon, S. (1986). "Chorec fibrillaire de Morvan" followed by Guillain-barre syndrome in a putient receiving gold therapy [letter]. Arthritis and Rheumotism, 29, 1413-1414.
  • Warren, H. V. (1989). Geology, trace elements and health. Social Science and Medicine, 29, 923-926.
  • Weatherall, M. (1993). Drug therapies, In Hynum, W. F., & Roper, R. Eds. Companion cocyclopedia of the history of medicine. New York: Routledge. pp. 915-938.
  • Weisman, M. H. Albert, D., Mueller, M. R. Zraifler, N. J., Hesketh, S. A. & Shragg. G. P. (1983). Gold therapy in patients with systemic lupus crythematosus. American Journal of Medicine, 75, 157-164.
  • Weiss, J. J., Thompson, G. R., & Lazaru, R. (1982). Gold toxicity presenting as peripheral neuropathy. Clinical Rheumatology, 1, 285-289.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.